X-Chromosome Inactivation Status and Premature Ovarian Failure
NCT00295087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2014-12-08
Summary
Women who are affected with premature ovarian failure will exhibit skewed X-chromosome inactivation patterns compared to women with normal menstrual function (as defined by being pregnant), indicating a possible X-chromosome defect.
Conditions
- Premature Ovarian Failure
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
W. Allen Hogge, MD · University of Pittsburgh and Magee-Womens Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-11-30
- Primary Completion
- 2009-10-31
- Completion
- 2009-10-31
Countries
- United States
Study Locations
More Related Trials
-
Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care
NCT04661072 ·Status: RECRUITING
-
Incidence of Early Pregnancy Loss in Patients With Unexplained Infertility
NCT01015690 ·Status: COMPLETED
-
A Study Looking at Women's Experiences After a Miscarriage
NCT01223482 ·Status: UNKNOWN
-
Genomic and Epigenomic Alterations After Cancer Treatment in Pregnancy
NCT04125446 ·Status: UNKNOWN
-
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346 ·Status: COMPLETED
-
Antenatal Detection by Array CGH Genomic Rearrangements Unbalanced Front Uninsulated Thick Neck or a Combination of Two Signs of Ultrasound Calling Normal Karyotype
NCT03239002 ·Status: COMPLETED
-
Non-invasive Prenatal Diagnosis of Monogenic Disorders by Linked-reads Technology
NCT03622892 ·Status: UNKNOWN
-
Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders
NCT02339402 ·Status: UNKNOWN
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
PLAC1 in Reproduction
NCT01277848 ·Status: COMPLETED
-
Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
NCT02991729 ·Status: COMPLETED ·Phase: NA
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
NCT06523543 ·Status: RECRUITING
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399 ·Status: COMPLETED
-
PAR Family Polymorphisms and Placental Invasion Disorders
NCT00425867 ·Status: UNKNOWN
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Doppler and Biological Second Trimester Placental Insufficiency Screening
NCT00465634 ·Status: COMPLETED
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Prediction of Recurrent Pregnancy Loss by a New Thrombophilia Based Genetic Risk Score
NCT03336463 ·Status: COMPLETED
-
Technical Feasibility of the cfDNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray
NCT05900076 ·Status: COMPLETED
-
Screening for Sacral Agenesis in Offspring of Mothers With Diabetes in Pregnancy
NCT05033275 ·Status: TERMINATED
-
Expanded NIPT for Pregnancy Complications
NCT04311749 ·Status: COMPLETED
-
Prevalence of Ambivalence Regarding Prenatal Testing
NCT00342069 ·Status: COMPLETED